S dng ng liu lng c khuyn co ca nh sn xut
The potential connection between GLP-1 receptor agonists and Parkinson's disease stems from the presence of GLP-1 receptors in the brain , including the substantia nigra, hippocampus, and cortex
Semaglutide is often light-sensitive
Allosteric (off active site) activators were reported in the literature as early as the mid-2000s, but they had poor potency, poor pharmacokinetics, species-selective activity (human but not rodent), and none made it close to the clinic
Researchers comparing microdosing tirzepatide protocols should consider meal timing as a variable that can affect side effects and efficacy
How would the addition of a GLP-1RA compare to other second-line add-on therapies in improving management of the T2DM